These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22507920)

  • 21. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia.
    Park AJ; Paraiso MFR
    Obstet Gynecol; 2009 Aug; 114(2 Pt 2):484-487. PubMed ID: 19622971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome.
    Bertolasi L; Frasson E; Cappelletti JY; Vicentini S; Bordignon M; Graziottin A
    Obstet Gynecol; 2009 Nov; 114(5):1008-1016. PubMed ID: 20168100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of botulinum toxin in the treatment of achalasia.
    Schiano TD; Parkman HP; Miller LS; Dabezies MA; Cohen S; Fisher RS
    Dig Dis; 1998; 16(1):14-22. PubMed ID: 9549033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin: from spasticity reliever to a neuromotor re-learning tool.
    Krishnan RV
    Int J Neurosci; 2005 Oct; 115(10):1451-67. PubMed ID: 16162450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L; Salazar Z; Micheli F
    Clin Neuropharmacol; 2009; 32(3):165-6. PubMed ID: 19483486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of botulinum toxin for pediatric cricopharyngeal achalasia.
    Messner A; Ho AS; Malhotra PS; Koltai PJ; Barnes MA
    Int J Pediatr Otorhinolaryngol; 2011 Jun; 75(6):830-4. PubMed ID: 21501882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for effectiveness of botulinum toxin for hyperhidrosis.
    Bhidayasiri R; Truong DD
    J Neural Transm (Vienna); 2008; 115(4):641-5. PubMed ID: 17885725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Botulinum toxin injection in the management of achalasia.
    Ramzan Z; Nassri AB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN; Hovestadt A
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.
    Watts CR; Truong DD; Nye C
    J Neural Transm (Vienna); 2008; 115(4):625-30. PubMed ID: 17564757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin treatment of infantile esotropia in children.
    Ing MR
    Arch Ophthalmol; 1998 Jun; 116(6):833. PubMed ID: 9639468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.